Index of All Hepatitis B Articles by Topic ( A to Z)

PEG-Intron plus Epivir-HBV

Comparison of Pegylated Interferon Alfa-2b (Peg-Intron) and Lamivudine with Lamivudine Alone for the Treatment of Hepatitis B - 2/25/05

Pegylated Interferon Alfa-2b Alone or in Combination with Lamivudine for HBeAg-positive Chronic Hepatitis B: Results of a Randomised Trial
- 01/07/05

Combination of Peginterferon Alfa-2b and Lamivudine Is Superior to Lamivudine Alone in the Treatment of Chronic Hepatitis B Infection
- 05/21/04


Peginterferon Alfa-2b Plus Lamivudine Is Associated with Higher Response Rates Than Lamivudine Monotherapy in HBeAg-positive Chinese Patients  - 05/03/04


Combination Therapy with Lamivudine Plus Conventional Interferon Prevents or Delays the Emergence of Lamivudine Resistance
 - 05/03/04

Peginterferon Alone and in Combination with Lamivudine Improves Liver Histology in Chronic HBV Patients, but Does Not Reduce Fibrosis - 04/30/04


Combination Therapy with Peginterferon Alfa-2b (PEG-IFN) and Lamivudine Is More Effective Than PEG-IFN Alone, But Does Not Result in Greater Sustained Response Rates - 04/30/04

Peginterferon Alfa-2b (PEG-Intron)
Monotherapy and in Combination with Lamivudine Improves Liver Histology in Chronic HBV Patients but Does Not Significantly Improve Fibrosis - 04/21/04

 

 

 

 

 






 

 

 

 

 

 

 

 

 

 




























Google


FDA-approved
Monotherapies for HBV

Baraclude
  (entecavir)
 Epivir-HBV
  (lamivudine; 3TC)
Intron A
  (interferon alfa-2b)
Hepsera
  (adefovir dipivoxil)
Pegasys
  (peginterferon alfa-2a)
Tyzeka
  (telbivudine)

HEPATITIS B
THERAPIES CHART

TOP NEW
HEPATITS B ARTICLES